OBJECTIVES: SLC2A9 gene variants associate with serum uric acid in white populations, but little is known about African American populations. Since SLC2A9 is a transporter, gene variants may be expected to associate more closely with the fractional excretion of urate, a measure of renal tubular transport, than with serum uric acid, which is influenced by production and extrarenal clearance. METHODS: Genotypes of single nucleotide polymorphisms (SNPs) distributed across the SLC2A9 gene were obtained in the Genetic Epidemiology Network of Arteriopathy cohorts. The associations of SNPs with serum uric acid, fractional excretion of urate and urine urate-to-creatinine ratio were assessed with adjustments for age, sex, diuretic use, BMI, homocysteine and triglycerides. RESULTS: We identified SLC2A9 gene variants that were associated with serum uric acid in 1155 African American subjects (53 SNPs) and 1132 white subjects (63 SNPs). The most statistically significant SNPs in African American subjects (rs13113918) and white subjects (rs11723439) were in the latter half of the gene and explained 2.7 and 2.8% of the variation in serum uric acid, respectively. After adjustment for this SNP in African Americans, 0.9% of the variation in serum uric acid was explained by an SNP (rs1568318) in the first half of the gene. Unexpectedly, SLC2A9 gene variants had stronger associations with serum uric acid than with fractional excretion of urate. CONCLUSIONS: These findings support two different loci by which SLC2A9 variants affect uric acid levels in African Americans and suggest SLC2A9 variants affect serum uric acid level via renal and extrarenal clearance.
OBJECTIVES:SLC2A9 gene variants associate with serum uric acid in white populations, but little is known about African American populations. Since SLC2A9 is a transporter, gene variants may be expected to associate more closely with the fractional excretion of urate, a measure of renal tubular transport, than with serum uric acid, which is influenced by production and extrarenal clearance. METHODS: Genotypes of single nucleotide polymorphisms (SNPs) distributed across the SLC2A9 gene were obtained in the Genetic Epidemiology Network of Arteriopathy cohorts. The associations of SNPs with serum uric acid, fractional excretion of urate and urine urate-to-creatinine ratio were assessed with adjustments for age, sex, diuretic use, BMI, homocysteine and triglycerides. RESULTS: We identified SLC2A9 gene variants that were associated with serum uric acid in 1155 African American subjects (53 SNPs) and 1132 white subjects (63 SNPs). The most statistically significant SNPs in African American subjects (rs13113918) and white subjects (rs11723439) were in the latter half of the gene and explained 2.7 and 2.8% of the variation in serum uric acid, respectively. After adjustment for this SNP in African Americans, 0.9% of the variation in serum uric acid was explained by an SNP (rs1568318) in the first half of the gene. Unexpectedly, SLC2A9 gene variants had stronger associations with serum uric acid than with fractional excretion of urate. CONCLUSIONS: These findings support two different loci by which SLC2A9 variants affect uric acid levels in African Americans and suggest SLC2A9 variants affect serum uric acid level via renal and extrarenal clearance.
Authors: Richard J Johnson; Mark S Segal; Titte Srinivas; Ahsan Ejaz; Wei Mu; Carlos Roncal; Laura G Sánchez-Lozada; Michael Gersch; Bernardo Rodriguez-Iturbe; Duk-Hee Kang; Jaime Herrera Acosta Journal: J Am Soc Nephrol Date: 2005-04-20 Impact factor: 10.121
Authors: Robert Augustin; Mary O Carayannopoulos; Lia O Dowd; John E Phay; Jeffrey F Moley; Kelle H Moley Journal: J Biol Chem Date: 2004-01-22 Impact factor: 5.157
Authors: Daniel E Weiner; Hocine Tighiouart; Essam F Elsayed; John L Griffith; Deeb N Salem; Andrew S Levey Journal: J Am Soc Nephrol Date: 2008-03-12 Impact factor: 10.121
Authors: Paul R Daniels; Sharon L R Kardia; Craig L Hanis; C Andrew Brown; Richard Hutchinson; Eric Boerwinkle; Stephen T Turner Journal: Am J Med Date: 2004-05-15 Impact factor: 4.965
Authors: Afshin Parsa; Eric Brown; Matthew R Weir; Jeffrey C Fink; Alan R Shuldiner; Braxton D Mitchell; Patrick F McArdle Journal: Kidney Int Date: 2011-12-21 Impact factor: 10.612
Authors: Wenhua Wei; Gibran Hemani; Andrew A Hicks; Veronique Vitart; Claudia Cabrera-Cardenas; Pau Navarro; Jennifer Huffman; Caroline Hayward; Sara A Knott; Igor Rudan; Peter P Pramstaller; Sarah H Wild; James F Wilson; Harry Campbell; Malcolm G Dunlop; Nicholas Hastie; Alan F Wright; Chris S Haley Journal: PLoS One Date: 2011-08-19 Impact factor: 3.240
Authors: V Saroja Voruganti; Nora Franceschini; Karin Haack; Sandra Laston; Jean W MacCluer; Jason G Umans; Anthony G Comuzzie; Kari E North; Shelley A Cole Journal: Eur J Hum Genet Date: 2013-12-04 Impact factor: 4.246
Authors: P Hollingworth; R Sweet; R Sims; D Harold; G Russo; R Abraham; A Stretton; N Jones; A Gerrish; J Chapman; D Ivanov; V Moskvina; S Lovestone; P Priotsi; M Lupton; C Brayne; M Gill; B Lawlor; A Lynch; D Craig; B McGuinness; J Johnston; C Holmes; G Livingston; N J Bass; H Gurling; A McQuillin; P Holmans; L Jones; B Devlin; L Klei; M M Barmada; F Y Demirci; S T DeKosky; O L Lopez; P Passmore; M J Owen; M C O'Donovan; R Mayeux; M I Kamboh; J Williams Journal: Mol Psychiatry Date: 2011-10-18 Impact factor: 15.992
Authors: Sandra L Laston; V Saroja Voruganti; Karin Haack; Vallabh O Shah; Arlene Bobelu; Jeanette Bobelu; Donica Ghahate; Antonia M Harford; Susan S Paine; Francesca Tentori; Shelley A Cole; Jean W MacCluer; Anthony G Comuzzie; Philip G Zager Journal: Front Genet Date: 2015-01-30 Impact factor: 4.599
Authors: Erin B Ware; Ellen Riehle; Jennifer A Smith; Wei Zhao; Stephen T Turner; Sharon L R Kardia; John C Lieske Journal: PLoS One Date: 2015-07-13 Impact factor: 3.240